Nowadays, cancer, autoimmune disease and various immune related intractable diseases have become the obstacle that mankind is confronted with and has to overcome. Until now, surgery, chemical therapy and radiation therapy, etc. have been the main modes of treatment for cancer. However, numerous side effects and recurrences as well as the limits of these treatments have been reported. Moreover, in spite of the ardent efforts put into the development of a diverse range of medical products is being attempted in the area of autoimmune diseases, full cure through the treatment of the causes of the intractable diseases is yet to be achieved.

JW CreaGene is leading the development of new format of therapeutics based on immunology to free the mankind from various intractable diseases through dendritic cell researches. For this purpose, the company is dedicated to the development of manufacturing technology and improvement of the functions of dendritic cell, discovery of new antigens and development of delivery technology, achieving product competitiveness through the development of protein manufacturing technology as well as expansion of product items in the areas of antigens/cytokines, and broadening our technological capabilities through global partnership.

JW CreaGene shall continue to fully devote ourselves to the research and development with our utmost efforts in order to realize the goals of our company in the development of therapeutics under new concepts with less side effects but with excellent efficacy on the intractable diseases.
Yours sincerely,